Research Topics
| JULIE MAGARIAN BLANDERSummaryAffiliation: Mount Sinai School of Medicine Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Designing a type I interferon signaling phagosomeJ Magarian Blander
The Immunology Institute, Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA
Immunity 37:947-9. 2012..In this issue of Immunity, Henault et al. (2012) show that Fcγ-receptor, Toll-like receptor 9, and LC3 conspire to mold phagosomes into type I interferon signaling platforms...
Revisiting the old link between infection and autoimmune disease with commensals and T helper 17 cellsJ Magarian Blander
Department of Medicine, Mount Sinai School of Medicine, Immunology Institute, 1425 Madison Avenue, New York, NY 10029, USA
Immunol Res 54:50-68. 2012..We speculate on how the intricate relationships among commensal, pathogen, and the host might ultimately determine susceptibility to autoimmune disease...
Beyond pattern recognition: five immune checkpoints for scaling the microbial threatJ Magarian Blander
Mount Sinai School of Medicine, Immunology Institute, Department of Medicine, 1425 Madison Avenue, New York, New York 10029, USA
Nat Rev Immunol 12:215-25. 2012..Here, we propose five immune checkpoints that, as defined here, collectively determine the gravity of microbial encounters...
On regulation of phagosome maturation and antigen presentationJ Magarian Blander
Center for Immunobiology, Mount Sinai School of Medicine, New York, New York 10029, USA
Nat Immunol 7:1029-35. 2006..An inducible mode of phagosome maturation triggered by these receptors ensures the selection of microbial antigens for presentation by major histocompatibility class II molecules during the simultaneous phagocytosis of self and non-self...
Coupling Toll-like receptor signaling with phagocytosis: potentiation of antigen presentationJ Magarian Blander
Center for Immunobiology, Mount Sinai School of Medicine, NY 10029, USA
Trends Immunol 28:19-25. 2007....
Signalling and phagocytosis in the orchestration of host defenceJ Magarian Blander
Center for Immunobiology, Mount Sinai School of Medicine, 1425 Madison Avenue, New York, NY 10029, USA
Cell Microbiol 9:290-9. 2007..This mechanism prevents the potential presentation of peptides derived from self within the context of TLR-induced co-stimulatory signals...
Phagocytosis and antigen presentation: a partnership initiated by Toll-like receptorsJ Magarian Blander
Department of Medicine, Mount Sinai School of Medicine, Immunology Institute, New York, USA
Ann Rheum Dis 67:iii44-9. 2008..This current work aims to identify whether TLRs exert similar control on the presentation of phagocytosed antigens within MHC class I molecules, a process referred to as cross-presentation...
Prothymosin-alpha inhibits HIV-1 via Toll-like receptor 4-mediated type I interferon inductionArevik Mosoian
Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA
Proc Natl Acad Sci U S A 107:10178-83. 2010..Understanding the mechanism of IFN induction by ProTalpha may provide therapeutic leads for IFN-sensitive viruses...
Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell functionLeif E Sander
Department of Medicine III, RWTH University Hospital, 52074 Aachen, Germany
J Exp Med 207:1453-64. 2010..Thus, gp130-dependent communication between the liver and MDSCs through APPs controls inflammatory responses during infection...
Innate immune recognition of infected apoptotic cells directs T(H)17 cell differentiationMiriam Beer Torchinsky
Immunology Institute, Department of Medicine, Mount Sinai School of Medicine, 1425 Madison Avenue, New York, New York 10029, USA
Nature 458:78-82. 2009..Because T(H)17 cells have been correlated with autoimmune diseases, investigation of the pathways of innate recognition of infected apoptotic cells might lead to improved understanding of the causative defects in autoimmunity...
T helper 17 cells: discovery, function, and physiological triggerMiriam Beer Torchinsky
Department of Medicine, Immunology Institute, Mount Sinai School of Medicine, 1425 Madison Avenue, New York, NY 10029, USA
Cell Mol Life Sci 67:1407-21. 2010..As our knowledge of T(H)17 and T regulatory cells grows, we are building on a new framework for the understanding of effector T cell differentiation and the biology of CD4(+) T cell adaptive immune responses...
The unexpected link between infection-induced apoptosis and a TH17 immune responseCorinna F Brereton
Mount Sinai School of Medicine, Immunology Institute, Department of Medicine, 1425 Madison Ave, 12 20D, New York, NY 10029, USA
J Leukoc Biol 89:565-76. 2011..We also consider types of cell death other than apoptosis that can be triggered by microbial infection, and we highlight how little we know about the impact of various forms of cell death on the ensuing adaptive immune response...
Responding to infection and apoptosis--a task for TH17 cellsCorinna F Brereton
Department of Medicine, Immunology Institute, Mount Sinai School of Medicine, New York, New York 10029, USA
Ann N Y Acad Sci 1209:56-67. 2010....
Analysis of the TLR/NF-kappaB pathway in antigen-presenting cells in malignancies promoted by inflammationJ Magarian Blander
Department of Medicine, Immunology Institute, Mount Sinai School of Medicine, New York, NY, USA
Methods Mol Biol 512:99-117. 2009..Understanding the details of these pathways will aid in the development of new diagnostic and therapeutic applications...
Recognition of a specific self-peptide: self-MHC class II complex is critical for positive selection of thymocytes expressing the D10 TCRTao Dao
Laboratory of T Cell Immunobiology, Immunology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
J Immunol 170:48-54. 2003..Therefore, the recognition of self that promotes positive selection of the D10 TCR is highly peptide-specific...
Research Grants
- The Regulatory Control Mechanisms of Cross-presentation by Toll-like ReceptorsJULIE MAGARIAN BLANDER; Fiscal Year: 2010..The new knowledge we gain will further the design of therapeutic anti-viral and anti-tumor vaccines, and broaden our understanding of autoimmunity. ..
- The Regulatory Control Mechanisms of Cross-presentation by Toll-like ReceptorsJULIE MAGARIAN BLANDER; Fiscal Year: 2007..The new knowledge we gain will further the design of therapeutic anti-viral and anti-tumor vaccines, and broaden our understanding of autoimmunity ..
